Short answer
CARLSMED, INC. (CARL) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $19M (down 15.0% year over year) with net income of −$11M.
Q2 2026 key financials · XBRL
- Revenue
- $19M
- −15.0% YoY · +17.5% QoQ
- Net income
- −$11M
- +15.9% YoY · −20.9% QoQ
- Operating margin
- -58.3%
- Gross margin
- 76.8%
- EPS (diluted)
- −$0.39
- +86.7% YoY · −21.9% QoQ
Source: XBRL data from the CARLSMED, INC. (CARL) Q2 2026 10-Q on SEC EDGAR. USD.
CARLSMED, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes identified; filing provides only forward-looking risk references, not a substantive Risk Factors section
- Regulatory risk: aprevo Technology Platform requires applicable regulatory approvals before commercialization
- Operational risk: reliance on a limited number of contract manufacturing organizations
- Market risk: surgeon and hospital adoption may not meet expectations
- Financial risk: potential need for additional financing and capital availability uncertainty
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CARLSMED, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.